Krist Robert John 4

Accession 0001209191-12-057472

CIK 0001013606other

View on SEC.gov Company Profile

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 5:06 PM ET

Size

50.0 KB

Accession

0001209191-12-057472

Insider Transaction Report

Form 4

Period: 2012-12-11

ENDOLOGIX INC /DE/ELGX

Krist Robert John

Chief Financial Officer

Transactions

Sale
Common Stock
2012-12-11$14.03/sh−3,714$52,107→ 350,475 total
Sale
Common Stock
2012-12-11$14.14/sh−8,322$117,673→ 273,001 total
Sale
Common Stock
2012-12-11$14.13/sh−6,800$96,084→ 266,201 total
Sale
Common Stock
2012-12-11$14.11/sh−5,013$70,733→ 258,050 total
Exercise/Conversion
Option to Purchase
2012-12-11−30,000→ 0 total
Exercise: $3.40From: 2007-05-23Exp: 2016-05-23→ Common Stock (30,000 underlying)
Exercise/Conversion
Option to Purchase
2012-12-11−60,000→ 0 total
Exercise: $2.88From: 2009-02-12Exp: 2018-02-12→ Common Stock (60,000 underlying)
Sale
Common Stock
2012-12-11$14.05/sh−4,100$57,605→ 417,436 total
Sale
Common Stock
2012-12-11$14.04/sh−6,696$94,012→ 354,189 total
Sale
Common Stock
2012-12-11$14.02/sh−25,804$361,772→ 320,436 total
Sale
Common Stock
2012-12-11$14.05/sh−1,050$14,753→ 172,236 total
Sale
Common Stock
2012-12-11$14.06/sh−8,059$113,310→ 142,236 total
Exercise/Conversion
Option to Purchase
2012-12-11−37,000→ 0 total
Exercise: $4.32From: 2008-05-22Exp: 2017-05-22→ Common Stock (37,000 underlying)
Award
Common Stock
2012-12-11$5.55/sh+4,100$22,755→ 324,536 total
Award
Common Stock
2012-12-11$3.40/sh+30,000$102,000→ 320,436 total
Sale
Common Stock
2012-12-11$14.00/sh−37,435$524,090→ 380,001 total
Sale
Common Stock
2012-12-11$14.09/sh−2,700$38,043→ 219,536 total
Award
Common Stock
2012-12-11$2.88/sh+60,000$172,800→ 421,536 total
Sale
Common Stock
2012-12-11$14.05/sh−19,116$268,580→ 360,885 total
Sale
Common Stock
2012-12-11$14.15/sh−39,113$553,449→ 281,323 total
Sale
Common Stock
2012-12-11$14.10/sh−35,814$504,977→ 222,236 total
Sale
Common Stock
2012-12-11$14.08/sh−1,700$23,936→ 217,836 total
Sale
Common Stock
2012-12-11$14.06/sh−23,203$326,234→ 173,286 total
Award
Common Stock
2012-12-11$4.32/sh+37,000$159,840→ 361,536 total
Sale
Common Stock
2012-12-11$14.01/sh−4,235$59,332→ 346,240 total
Sale
Common Stock
2012-12-11$14.12/sh−3,138$44,309→ 263,063 total
Sale
Common Stock
2012-12-11$14.07/sh−21,347$300,352→ 196,489 total
Sale
Common Stock
2012-12-11$14.20/sh−21,941$311,562→ 150,295 total
Exercise/Conversion
Option to Purchase
2012-12-11−4,100→ 95,900 total
Exercise: $5.55From: 2005-08-18Exp: 2014-08-18→ Common Stock (4,100 underlying)

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

ENDOLOGIX INC /DE/

CIK 0001013606

→

Entity typeother

Related Parties

filerCIK 0001301171

Filing Metadata

Form type: 4
Filed: Dec 12, 7:00 PM ET
Accepted: Dec 13, 5:06 PM ET
Size: 50.0 KB

View on SEC.gov